Literature DB >> 28933063

Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease.

Susana Cardoso1,2, Raquel Seiça3, Paula I Moreira4,3.   

Abstract

It is widely accepted that high calorie diets and a sedentary lifestyle sturdily influence the incidence and outcome of type 2 diabetes and obesity, which can occur simultaneously, a situation called diabesity. Tightly linked with metabolic and energy regulation, a close association between diabetes and Alzheimer's disease (AD) has been proposed. Among the common pathogenic mechanisms that underpin both conditions, insulin resistance, brain glucose hypometabolism, and metabolic dyshomeostasis appear to have a pivotal role. This century is an unprecedented diabetogenic period in human history, so therapeutic strategies and/or approaches to control and/or revert this evolving epidemic is of utmost importance. This chapter will make a brief contextualization about the impact that diabetes and obesity can exert in brain structure and function alongside with a brief survey about the role of insulin in normal brain function, exploring its roles in cognition and brain glucose metabolism. Later, attention will be given to the intricate relation of diabesity, insulin resistance, and AD. Finally, both pharmacological and lifestyle interventions will also be reviewed as strategies aimed at fighting diabesity and/or AD-related metabolic effects.

Entities:  

Keywords:  Alzheimer’s disease; Brain; Diabesity; Glucose metabolism; Insulin resistance

Mesh:

Substances:

Year:  2017        PMID: 28933063     DOI: 10.1007/978-3-319-63260-5_5

Source DB:  PubMed          Journal:  Adv Neurobiol


  6 in total

Review 1.  Role of the chanzyme TRPM7 in the nervous system in health and disease.

Authors:  Nashat Abumaria; Wei Li; Andrew N Clarkson
Journal:  Cell Mol Life Sci       Date:  2019-05-09       Impact factor: 9.261

Review 2.  Oxygen Sensing and Signaling in Alzheimer's Disease: A Breathtaking Story!

Authors:  Sónia C Correia; Paula I Moreira
Journal:  Cell Mol Neurobiol       Date:  2021-09-12       Impact factor: 5.046

3.  Diastereomeric Mixture of Calophyllic and Isocalophyllic Acid Ameliorates Scopolamine-Induced Memory Impairment in Mice: Involvement of Antioxidant Defense and Cholinergic Systems.

Authors:  I O Ishola; A A Akinyede; J E Eloke; J P Chaturvedi; T Narender
Journal:  Neurotox Res       Date:  2019-10-26       Impact factor: 3.911

Review 4.  Insulin and Its Key Role for Mitochondrial Function/Dysfunction and Quality Control: A Shared Link between Dysmetabolism and Neurodegeneration.

Authors:  Giacoma Galizzi; Marta Di Carlo
Journal:  Biology (Basel)       Date:  2022-06-20

5.  Bioinformatics analysis of differentially expressed genes and identification of an miRNA-mRNA network associated with entorhinal cortex and hippocampus in Alzheimer's disease.

Authors:  Haoming Li; Linqing Zou; Jinhong Shi; Xiao Han
Journal:  Hereditas       Date:  2021-07-09       Impact factor: 3.271

6.  Liraglutide Protects Against Brain Amyloid-β1-42 Accumulation in Female Mice with Early Alzheimer's Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation.

Authors:  Ana I Duarte; Emanuel Candeias; Inês N Alves; Débora Mena; Daniela F Silva; Nuno J Machado; Elisa J Campos; Maria S Santos; Catarina R Oliveira; Paula I Moreira
Journal:  Int J Mol Sci       Date:  2020-03-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.